8SDO image
Entry Detail
PDB ID:
8SDO
Keywords:
Title:
ATAD2 bromodomain in complex with "oncohistone" mutation H4S1CK5ac (res 1-15) ligand
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-04-07
Release Date:
2024-06-05
Method Details:
Experimental Method:
Resolution:
2.01 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 43 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ATPase family AAA domain-containing protein 2
Mutations:C1101A
Chain IDs:A
Chain Length:152
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Histone H4
Mutations:S1C
Chain IDs:B
Chain Length:15
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains.
J.Med.Chem. 67 8186 8200 (2024)
PMID: 38733345 DOI: 10.1021/acs.jmedchem.4c00210

Abstact

The ATPase family AAA+ domain containing 2 (ATAD2) protein and its paralog ATAD2B have a C-terminal bromodomain (BRD) that functions as a reader of acetylated lysine residues on histone proteins. Using a structure-function approach, we investigated the ability of the ATAD2/B BRDs to select acetylated lysine among multiple histone post-translational modifications. The ATAD2B BRD can bind acetylated histone ligands that also contain adjacent methylation or phosphorylation marks, while the presence of these modifications significantly weakened the acetyllysine binding activity of the ATAD2 BRD. Our structural studies provide mechanistic insights into how ATAD2/B BRD-binding pocket residues coordinate the acetyllysine group in the context of adjacent post-translational modifications. Furthermore, we investigated how sequence changes in amino acids of the histone ligands impact the recognition of an adjacent acetyllysine residue. Our study highlights how the interplay between multiple combinations of histone modifications influences the reader activity of the ATAD2/B BRDs, resulting in distinct binding modes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures